Remote Intervention to Prevent Overdose

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

This Type 1 hybrid effectiveness-implementation randomized controlled trial, A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or Opioids, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of remote education on overdose outcomes, using a novel 2x2 design crossing remote education with remote access support. This research will inform scalability around remote education programs to address the nation's opioid overdose crisis.

Eligibility criteria

Qualifiers

18 years old

English-speaking and reading

Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST

Able and willing to provide informed consent

Disqualifiers

Living in a restricted environment (e.g., prison)

Trial design

Treatments tested in this trial

  • Overdose prevention resources
  • Overdose prevention education

Treatment groups

100 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator